Incyte Corporation

06/13/2022 | Press release | Distributed by Public on 06/13/2022 14:35

Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47